CDK8 and neoplasm: To address the relevance of CDK8 in NK-cell-mediated recognition in an in vivo setting, we orthotopically injected CDK8-deficient and wild-type tumor cells into recombination activating gene 2 knockout (Rag2−/−) mice that rely on NK cells for tumor surveillance but lack T and B cells (Fig. 4A).